AstraZeneca Invests US$1.3 Million for Youth Health in Indonesia
Global pharmaceutical company, AstraZeneca, has just announced a major commitment to support public health in Indonesia. Through a program called the Young Health Programme, the company is investing US$1.3 million, or approximately Rp20 billion.
The main focus of this investment is to improve the quality of health for the younger generation in Indonesia. The program is designed to provide education as well as tangible support in the prevention of various types of diseases that often affect the younger age group.
In addition to providing education, AstraZeneca is also striving to build awareness of the importance of a healthy lifestyle from an early age. This step is expected to help the young generation of Indonesia be more proactive in maintaining their own health in the future.
This investment is part of the company's ongoing efforts to contribute to the national health system. With this funding support, it is hoped that the reach of health programs for adolescents and young adults can be expanded to various regions in Indonesia.
Overall, this initiative demonstrates the important role of the private sector in supporting the government's health targets. It is hoped that this program can provide a significant positive impact on improving the quality of life for the younger generation throughout the country.